Literature DB >> 728223

Effects of administration of di-(2-ethylhexyl)phthalate on rat liver mitochondria.

Y Shindo, T Osumi, T Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 728223     DOI： 10.1016/0006-2952(78)90042-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Measurement of fatty acid oxidation rates in animal tissues and cell lines.

Authors:  Frank K Huynh; Michelle F Green; Timothy R Koves; Matthew D Hirschey
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.

Authors:  Hyun-Seok Kim; Cuiying Xiao; Rui-Hong Wang; Tyler Lahusen; Xiaoling Xu; Athanassios Vassilopoulos; Guelaguetza Vazquez-Ortiz; Won-Il Jeong; Ogyi Park; Sung Hwan Ki; Bin Gao; Chu-Xia Deng
Journal:  Cell Metab       Date:  2010-09-08       Impact factor: 27.287

3.  Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.

Authors:  Y Nemoto; K Toda; M Ono; K Fujikawa-Adachi; T Saibara; S Onishi; H Enzan; T Okada; Y Shizuta
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

4.  Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice.

Authors:  Tetsu Egawa; Katsumi Toda; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisaw; Toshiji Saibara; Yoshihiro Hayashi; Makoto Hiroi; Hideaki Enzan; Saburo Onishi
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

5.  Quantitative immunocytochemical studies on differential induction of serine:pyruvate aminotransferase in mitochondria and peroxisomes of rat liver cells by administration of glucagon or di-(2-ethylhexyl)phthalate.

Authors:  S Yokota
Journal:  Histochemistry       Date:  1986

6.  Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone.

Authors:  P S Foxworthy; P I Eacho
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.